CRC-derived exosomal HSPC111 activates HSCs by altering the acetyl-CoA levels, citrate content and phosphorylation of ATP-citrate lyase (ACLY), causing them to exhibit a profibrogenic phenotype similar to CAFs [241]. Here, ACLY is linked to colorectal carcinoma.